Meril’s groundbreaking trial demonstrates the efficacy and safety of the MGuard™ device, marking a major milestone in cardiovascular treatment and paving the way for improved patient outcomes worldwide...
New bioengineered device aims to transform treatment of peripheral nerve injuries with first-in-human evaluation now underway....
New investment to accelerate global rollout of Koning’s 3D breast imaging technology....
‘Neurophet AQUA AD’ demonstrates powerful clinical utility in early diagnosis and progression monitoring of Alzheimer’s disease....
New clinical research aims to validate safety and effectiveness of low-radiation imaging in real-world cardiac interventions. ...
New device combines advanced imaging with artificial intelligence under a dual-brand strategy to enhance global eye care accessibility....
Company highlights AI-driven, scalable imaging solutions designed to improve access and clinical performance....
Revvity’s Diagnostics Arm Launches EUROLabWorkstation ELISA to Boost Specialty Lab Efficiency ...
Collaboration Aims to Improve Early Detection and Treatment Outcomes for Alzheimer’s Patients Across the U.S....
Breakthrough device-based therapies offer new hope for patients unresponsive to conventional treatments. ...
